27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
Adaptimmune Therapeutics (NASDAQ:ADAP) reported its Q1 earnings results on Friday, May 12, 2023 at 07:30 AM.
Here's what investors need to know about the announcement.
Earnings
Adaptimmune Therapeutics missed estimated earnings by 100.0%, reporting an EPS of $0.0 versus an estimate of $-0.14.
Revenue was up $44.03 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.07 which was followed by a 5.3% drop in the share price the next day.
Here's a look at Adaptimmune Therapeutics's past performance:
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.25 | -0.24 | -0.25 | -0.22 |
| EPS Actual | -0.18 | -0.24 | -0.28 | -0.32 |
| Revenue Estimate | 4.12M | 4.04M | 6.00M | 3.29M |
| Revenue Actual | 11.03M | 7.01M | 5.54M | 3.58M |
To track all earnings releases for Adaptimmune Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!